MRK – Merck & Co Stock Premarket Price
MRK Premarket Chart
About Merck & Co Inc
Merck & Co. Inc. is a renowned multinational pharmaceutical company. Founded in 1891, Merck is recognized for its contributions to the healthcare sector, including the development of prescription drugs and vaccines. The company’s products address a wide range of medical conditions and health challenges. Merck’s commitment to medical research and innovation has led to significant advancements in the field of pharmaceuticals. As a leader in the healthcare industry, Merck continues to play a crucial role in improving global health and well-being.
Latest News
- Stocks making the biggest moves midday: Carrier, Johnson Controls, Chart Industries, Sarepta
- Tom Lee’s Granny Shots ETF rakes in $2 billion in AUM just 9 months after inception
- JPMorgan Chase is nearing a deal to replace Goldman Sachs as Apple Card issuer, sources say
- Stocks making the biggest moves premarket: Novo Nordisk, Whirlpool, Sarepta Therapeutics and more
- With Trump pressure and a ‘new Lebanon,’ can Hezbollah’s shadow economy be dismantled?
- Barclays second-quarter profit beats estimates as investment banking revenues swell
- Stocks making the biggest moves after hours: Cadence Design Systems, Whirlpool, Nucor and more
- JPMorgan says fintech middlemen like Plaid are ‘massively taxing’ its systems with unnecessary pings
- Stocks making the biggest moves midday: Tesla, Nike, Revvity, Anheuser-Busch and more
- Stocks making big premarket moves: Cheniere Energy, Nike, Kratos, ASML and more
- China’s latest AI model claims to be even cheaper to use than DeepSeek
- Quantum computing firm IonQ hires former JPMorgan Chase applied research head
- Where is Nvidia? Chinese rivals take the limelight at major AI event in Shanghai
- ‘This market is pricing in perfection,’ warns Verdence Capital CIO as tariff deadline looms
- Two brokers vie to be Asia’s Robinhood as Hong Kong expands crypto support
- AstraZeneca CEO doubles down on U.S. amid rumors of listing shift
- Starbucks doubles down on hospitality with ‘Green Apron Service’ strategy
- Spotify stock falls 6% on revenue miss, lackluster guidance
- Novo Nordisk shares plunge after Wegovy maker names new CEO, cuts full-year guidance
- Boeing slashes losses as CEO touts ‘our turnaround year’
- Meta’s AI spending spree is Wall Street’s focus in second-quarter earnings
- Procter & Gamble beats estimates but warns tariffs will start to weigh on earnings
- PayPal beats on earnings, raises full-year outlook as Venmo growth accelerates
- Merck plans $3 billion cost cuts by end of 2027, narrows full-year outlook
- UnitedHealth says 2025 earnings will be worse than expected as high medical costs dog insurers
- UPS posts downbeat quarterly results as shifting trade policies weigh
- Jeep maker Stellantis reinstates financial guidance but flags ‘tough decisions’ ahead
- Singapore Airlines shares fall more than 8% after first-quarter profit plunges
- China’s Laopu Gold shares fall despite forecast of tripling profits
- Earnings playbook: Reporting season ramps up with more ‘Magnificent 7’ results this week